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Abstract Immediately after sampling, leukocyte counts in
native cerebrospinal fluid (CSF) start to decrease rapidly. As
the time lapse between CSF collection to analysis is not
routinely registered, the clinical significance of decreasing
cell counts in native CSF is not known. Earlier data suggest
that addition of serum-containing medium to CSF directly
after sampling prevents this rapid decrease in leukocyte
counts and, thus, may improve the accuracy of CSF cell
counting and cell characterization. Here, we prospectively
examined the effect of storage time after lumbar puncture on
counts of leukocytes and their major subsets in both native
CSF and after immediate addition of serum-containing
medium, measured by flow cytometry and microscopy. We
collected CSF samples of 69 patients in tubes with and tubes
without serum-containing medium and determined counts
of leukocytes and subsets at 30 minutes, 1 hour, and 5 hours
after sampling. Compared to cell counts at 30 minutes, no
significant decrease in cell number was observed in CSF
with serum-containing medium 1 and 5 hours after sam-
pling, except for the granulocytes at 1 hour. In native CSF,
approximately 50% of leukocytes and all their subsets were
lost after 1 hour, both in flow cytometric and microscopic
counting. In 6/7 (86%) samples with mild pleocytosis
(5–15 9 106 leukocytes/l), native CSF at 1 hour was
incorrectly diagnosed as normocellular. In conclusion,
addition of serum-containing medium to CSF directly after
sampling prevents cell loss and allows longer preservation
of CSF cells prior to analysis, both for microscopic and flow
cytometric enumeration. We suggest that this protocol
results in more accurate CSF cell counts and may prevent
incorrect conclusions based on underestimated CSF cell
counts.
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Introduction
Cerebrospinal fluid (CSF) pleocytosis ([5 9 106 leuko-
cytes/l) may indicate an infectious or inflammatory etiol-
ogy of neurological symptoms [7]. Examples include viral,
tuberculous and aseptic meningitis, neurosarcoidosis,
neuro-Behc¸et, and paraneoplastic neurological syndromes.
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Earlier studies showed that leukocytes, derived from
blood or CSF, disappear rapidly when spiked into CSF
[3, 6, 12]. After 2 hours of storage in CSF, a leukocyte loss
of 15–62% [3, 6, 12] was observed, while after storage for
24 hours only 39–60% of leukocytes remained detectable
[3]. Furthermore, the delay from sampling to processing
has a differential effect on the various cell types in CSF and
affects the number of granulocytes most [6, 12].
However, the time from CSF collection to analysis is not
routinely registered, and the clinical significance of
decreasing cell counts in native CSF is not known. The
rapid cellular loss in CSF suggests that CSF of patients
with mild pleocytosis may be falsely diagnosed as nor-
mocellular depending on the time between lumbar puncture
(LP) and analysis of the sample. Addition of serum-con-
taining medium to CSF may prevent the rapid loss of
leukocytes and their subsets [13] and, thereby, improve the
accuracy of CSF cell counting and characterization.
In addition to the delay between sampling and analysis,
CSF cell counts may also be affected by the counting
method. Manual or microscopic analysis is the gold stan-
dard for determination of the (differential) white blood cell
(WBC; leukocyte) and red blood cell (RBC; erythrocyte)
counts in CSF. However, this technique is very time-con-
suming, costly, and prone to intertechnician variability and
low precision [1, 2]. Flow cytometry appears to improve
accuracy and precision of CSF cell counting [5, 9].
Moreover, flow cytometry permits differentiation of leu-
kocytes into lymphocytes and their subsets, monocytes and
granulocytes by immunophenotyping, whereas microscopic
analysis only differentiates between mononuclear cells
(MNC; lymphocytes and monocytes) and polymorphonu-
clear cells (PMN; granulocytes).
In this study, we prospectively examined the effect of
storage time after LP on counts of leukocytes and their
major subsets in both native CSF and after addition of
serum-containing medium, as measured by flow cytometry
and microscopy. The medium was added directly after LP
as it is known that cell decline starts immediately after CSF
sampling [3, 6, 11–13]. We determined the percentage of
CSF samples with mild pleocytosis that would be incor-
rectly diagnosed as normocellular when only native CSF
was examined. This study was conducted on CSF samples
of 69 patients.
Methods
Patients
A total of 61 patients with suspected neurological disease
were included between January and August 2009 at the
Department of Neurology, Daniel den Hoed Cancer Clinic,
Erasmus MC, Rotterdam. We included patients with sus-
pected or proven leptomeningeal localization of a hema-
tological or solid malignancy undergoing diagnostic or
therapeutic LP in our in- or outpatient clinic. Patients were
included only once. In addition, 8 patients without neuro-
logical disease undergoing spinal anesthesia for orthopedic,
gynecological, or general surgery were included between
May and August 2008 at the Department of Anesthesiol-
ogy, Sint Franciscus Gasthuis, Rotterdam. The local ethical
committees approved the study design and written
informed consent was obtained from all patients.
CSF collection
Up to 5 ml extra CSF was obtained from the 61 neuro-
logical patients during routine LP and aspirated before
administration of the anesthetic drug in the 8 anesthesio-
logical patients. Immediately after withdrawal, the CSF
was split into different sterile tubes with or without serum-
containing medium (1:1 dilution) and stored at room tem-
perature. The medium consisted of RPMI-1640 with
25 mM HEPES, 1 mM L-Glutamine, 2% penicillin/strep-
tomycin, 5% heat-inactivated fetal bovine serum (FBS),
and 2,500 IU heparin. This medium is routinely used in our
laboratory for preservation of CSF cells before analysis
[6, 10] and is stored in refrigerators in our in- and outpa-
tient clinical wards where LPs are performed. All reagents
were obtained from Cambrex Biosciences (Walkersville,
MD), except for FBS (Greiner Bio-One, Frickenhausen,
Germany) and heparin (Leo Pharma A/S, Ballerup,
Denmark). In CSF of the 61 neurological patients, cell
numbers were determined by flow cytometric and micro-
scopic counting at 30 minutes, 1 hour, and 5 hours after
sampling, while in CSF of the 8 patients who underwent
spinal anesthesia, cell numbers were counted by flow
cytometry only at 1 and 5 hours after sampling, due to
smaller sample sizes in these patients.
Flow cytometric counting
Numbers of leukocytes, lymphocytes, monocytes, and
granulocytes were determined by 6-color flow cytometry.
CSF cells were concentrated by centrifugation (8 minutes,
450 g) and resuspended in phosphate-buffered saline
(PBS). Next, the sample was incubated for 15 minutes at
room temperature (RT) in the dark with 10 ll of each of
the following monoclonal antibodies (mAb): CD3 conju-
gated with fluorescein isothiocyanate (FITC; clone SK7),
CD56 conjugated with phycoerythrin (PE; clone C5.9),
CD45 conjugated with peridinyl cholorophyllin (PerCP;
clone 2D1), CD4 conjugated with PE-Cy7 (clone SK3),
CD19 conjugated with allophycocyanin (APC; clone
HIB19), and CD8 conjugated with APC-Cy7 (clone SK1).
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All mAb were obtained from BD Biosciences (San Jose,
CA) with the exception of CD56-PE (Dako, Glostrup,
Denmark) and CD19-APC (eBioscience, San Diego, CA).
After incubation, cells were washed and subsequently
resuspended in PBS. Immediately upon staining, list mode
data were acquired on a 6-color FACSCanto flow cytom-
eter (BD Biosciences, San Jose, CA). Analysis was per-
formed using FCS Express software (De Novo Software,
Los Angeles, CA). In the flow cytometric analysis of this
study, we focused on leukocytes, lymphocytes, monocytes,
and granulocytes as microscopic enumeration could only
differentiate between leukocytes, mononuclear cells
(MNC; lymphocytes and monocytes), and granulocytes.
The immunophenotypical definitions of leukocytes and
their major subsets are shown in Table 1.
Microscopic counting
Microscopic counting was performed before washing or
concentration of the CSF. RBCs and WBCs were counted
in a Fuchs-Rosenthal counting chamber at 400x magnifi-
cation. First, RBCs were counted in unstained CSF. Next,
CSF was incubated with concentrated Tu¨rk reagent (crystal
violet dissolved in acetic acid; both obtained from Merck,
Darmstadt, Germany) (10:1) for 5 minutes to lyse the
RBCs and stain the WBCs. After incubation, WBCs were
counted and visual differentiation between MNC and PMN
was made. Subsequently, cell concentrations were calcu-
lated and corrected for dilution in medium.
Statistics
Because of the large variation in cell counts between
samples, we used ratios to present the data clearly. Spe-
cifically, we calculated ratios for medium (cell count in
native CSF divided by cell count in CSF with medium) in
paired samples, for flow cytometry and for microscopy.
These ratios were presented in box-and-whisker plots. To
present the effect of storage time, the cell survival in native
CSF and CSF with medium was determined ((i) cell count
at 1 hour divided by cell count at 30 minutes, and (ii) cell
count at 5 hours divided by cell count at 30 minutes) and
graphically presented. Groups were compared with the
Wilcoxon matched-pair test (SPSS version 15.0, SPSS Inc.,
Chicago, IL). Differences between groups with a
P-value \ 0.05 were considered significant.
Results
Patients
Patient characteristics are presented in Table 2. Due to
limited volumes of CSF in some patients, not all counting
methods could be performed at all three time points within
each sample. A total of 48 CSF samples were investigated
at 30 minutes with both flow cytometry and microscopy,
while at 1 hour flow cytometry was performed on 69
samples and microscopy on 61 samples. At 5 hours after
sampling, 27 CSF samples were studied by flow cytometry
and 19 by microscopy. Median and 25–75th percentiles of
paired flow cytometric enumerations are presented in the
Supplemental Table (published online).
Effect of storage time on CSF cell counts
Because it is not feasible to count cells directly after
sampling, we considered the cell count at 30 minutes as a
reasonable earliest measurement. Based on earlier data
[6, 10, 13], we postulated that addition of serum-containing
Table 1 Immunophenotypical definitions of leukocytes and their
subsets
Subset Immunophenotypical definition
Leukocytes CD45?
Lymphocytes CD45?, SSClo, FSCim
Monocytes CD45?, SSCim, FSChi, CD4dim
Granulocytes CD45?, SSChi
SSC side scatter, FSC forward scatter, hi high expression, im inter-
mediate expression, dim dim expression, lo low expression
Table 2 Patient characteristics
Variable
N 69
Age: median (range) 53 (20–77)
Gender (M/F) 42/27
Cerebrospinal fluid: median (range)
Glucose (mmol/l)* 3.5 (1.8–9.5)
Protein (g/l)* 0.34 (0.05–2.47)
Lactate dehydrogenase (U/l)* 43 (10–116)
RBC (9106/l) 0 (0–1,000)
WBC (9106/l)* 2 (0–356)
Reason for lumbar puncture
Diagnostic 33
Therapeutic 28
Spinal anesthesia 8
Malignancy
Hematological 43
Solid 18
No 8
RBC red blood cells, WBC white blood cells
* Reference ranges: glucose 2.5–3.7 mmol/l; protein 0.18–0.58 g/l;
lactate dehydrogenase 0–69 U/l; WBC 0–5 9 106/l
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medium immediately after CSF sampling, would prevent
cell loss and provide the most accurate estimation of the
number of cells in CSF at the time of sampling. We
approximated this situation by performing the first enu-
merations at 30 minutes after sampling, a time lapse nee-
ded for transport of the CSF sample to the laboratory and
setting up the counting procedure.
First, the effect of storage time after the addition of
serum-containing medium to CSF was evaluated. At 1 and
5 hours after sampling, no significant decrease in the
number of lymphocytes or monocytes counted by flow
cytometry was observed in CSF with serum-containing
medium as compared to 30 minutes after sampling
(Fig. 1a). However, granulocytes did decrease significantly
(P \ 0.005), which may be due to their very low counts in
our CSF samples (typically, CSF samples contained only
0.02–6.1 9 106 granulocytes/l vs. 0.01–43.3 9 106 lym-
phocytes/l). In native CSF (Fig. 1b), the leukocyte number
declined significantly over time (P \ 0.005), including the
number of monocytes (P \ 0.005) and granulocytes
(P \ 5910-6). The number of lymphocytes was stable at
both time points.
Addition of serum-containing medium immediately
after CSF sampling
Flow cytometry
At all time points, flow cytometric counts of leukocytes
and their subsets in native CSF were significantly lower
than in CSF with serum-containing medium, except for the
granulocyte count 30 minutes after sampling (Fig. 2).
Furthermore, the ratio between cell counts in CSF without
and with serum-containing medium decreased over time.
After 5 hours, only 56% of the lymphocytes were left in
native CSF (Fig. 2). The monocyte counts were affected
even more: only 34% of cells was still detectable after
5 hours (Fig. 2). Most of the cell loss in native CSF
occurred during the first hour after sampling, while the
differences between 1 and 5 hours were not significant
(data not shown).
At 1 hour after sampling, 15 of the 69 patients (22%)
had a pleocytosis (5–344 9 106 leukocytes/l) in the CSF
sample with serum-containing medium. This pleocytosis
was mild (5–15 9 106 leukocytes/l) in 7 patients. In the
native samples, normal leukocyte counts were observed in
6 of the 15 (40%) samples with pleocytosis and even in 6 of
7 (86%) samples with a mildy increased leukocyte count.
Microscopy
Microscopic counts of WBC, MNC, and PMN (Fig. 3)
were also significantly lower in native CSF compared to
CSF with serum-containing medium at all time points,
except for the PMN 30 minutes after sampling. When
using microscopic counting, PMN showed the greatest loss
in native CSF with a residual cell count of only 36% at
5 hours after sampling as compared to CSF stored in
serum-containing medium.
Discussion
We prospectively investigated the effect of adding serum-
containing medium to CSF directly after sampling on cell
counts determined by flow cytometry and microscopy in
CSF samples from 69 patients. Our findings show that
addition of serum-containing medium to CSF directly after
sampling not only prevents immediate cell loss, but also
allows longer preservation of CSF cells. The latter is
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Fig. 1 Median percentage of cell survival of leukocytes and their
subsets at 1 hour (N = 48) and 5 hours (N = 27) in CSF stored in
serum-containing medium (a) and native CSF (b) as determined by
flow cytometry. The cell count at 30 minutes is set at 100%. In CSF
with medium the number of granulocyted declined significantly
(P \ 0.005) at 1 and 5 hours. In native CSF, the number of
leukocytes (P \ 0.005), monocytes (P \ 0.005), and granulocytes
(P \ 5 9 10-6) declined significantly at 1 hour
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important for clinical practice. Especially after office
hours, CSF samples may remain unattended at room tem-
perature for considerable and unknown amounts of time: at
a busy emergency room, during prolonged transportation
towards the laboratory, and on the laboratory bench
pending analysis.
In CSF with a mild pleocytosis, WBC counting in
samples without addition of medium may result in a normal
cell count and pathology, e.g., neuroinflammatory disease,
may incorrectly be excluded. In our study, this situation
was observed in 40% of the samples with a pleocytosis and
even in 86% of the samples with a mildly increased WBC
count. This result indicates that addition of serum-con-
taining medium to CSF samples may prevent false-nega-
tive CSF interpretation and, thereby, impact clinical
decision-making.
In addition to the total number of WBCs, we also
studied the major WBC subsets. The selective loss of
granulocytes, in native clinical CSF samples as well as in
CSF with medium, has not been described earlier but is not
unexpected as even under ideal circumstances granulocytes
remain viable for only 7 hours [12]. Knowledge of this
selective cell loss is important, because it may result in
distortion of the relative size of cell populations [6] and,
thereby, affect clinical decisions (e.g., predominance of
granulocytes in CSF may differentiate early bacterial from
aseptic meningitis).
Different media can be added to CSF to reduce the cell
loss. Here, we show that addition of serum-containing
medium preserves CSF cells until at least 5 hours after
sampling. An earlier study showed that immediate addition
of Earle’s balanced salt solution with human serum albu-
min to CSF prevents total WBC loss until at least 24 hours
after sampling [13]. In this study, major WBC subsets were
not determined [13]. Other previous reports that investi-
gated CSF cell preservation methods were more laboratory
based than clinical. Spiking of CSF cells into 5% fetal calf
serum [6] or saline [12] showed no significant cell loss,
while spiking into acellular CSF did [6, 12]. In addition,
refrigeration of the CSF sample [3] and a minimum of
Leukocytes
P=1.2x10-4 P=1.2x10-10 P=7.0x10-6
Lymphocytes
P=9.6x10-5 P=3.7x10-8 P=1.7x10-5
setyconoM
P=5.7x10-5 P=2.6x10-10 P=6.3x10-6
setycolunarG
P=NS P=2.0x10-7 P=0.002
Fig. 2 Loss of cells in native CSF compared to CSF stored in serum-
containing medium as determined by flow cytometry. Ratios of cell
count in native CSF divided by cell count in CSF with serum-
containing medium in paired samples for flow cytometric leukocyte,
lymphocyte, monocyte, and granulocyte counts at 30 minutes
(N = 48), 1 hour (N = 69), and 5 hours (N = 27) after sampling.
Box-and-whisker plots were used to present the data graphically,
showing median and interquartile ranges; the whiskers extended to
the adjacent values, i.e., 1 9 the interquartile range rolled back to
where there is data. Observed points more extreme than the adjacent
values were considered outliers and have been plotted individually. P-
values (Wilcoxon matched-pair test) for the difference in cell counts
between CSF with and without serum-containing medium are given
WBC
P=0.006 P=0.0003 P=0.006
MNC
P=0.001 P=0.006 P=0.047
PMN
P=NS P=0.037 P=0.003
Fig. 3 Loss of cells in native CSF compared to CSF stored in serum-
containing medium as determined by microscopy. Ratios of cell count
in native CSF divided by cell count in CSF with serum-containing
medium in paired samples for microscopic white blood cell (WBC),
mononuclear cell (MNC), and polymorphonuclear cell (PMN) counts
at 30 minutes (N = 48), 1 hour (N = 61), and 5 hours (N = 19) after
sampling are presented in box-and-whisker plots. See Fig. 2
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centrifugation steps [6] also reduce cell loss. The function
of serum-containing media in preserving cells is probably a
buffering one. Both increase in pH after removal of CSF
from the body [4] and low osmolarity [8, 12] have been
postulated to cause cell death. Also, it remains to be
investigated which medium is the most effective in pre-
venting CSF cell loss in clinical settings from practical and
economic perspectives.
Based on the results of this study, we recommend add-
ing serum-containing medium to CSF directly after col-
lection, not only when CSF flow cytometry has to be
performed, but also when cells are routinely counted by
microscopy. Addition of serum-containing medium may
prevent false-negative reports of normal cell counts in CSF
samples with a mild pleocytosis. Although the conditions
and the maximal storage time to preserve CSF samples for
optimal cellular analyses still have to be optimized, we
may safely conclude that the use of native CSF samples for
such analyses should be discouraged.
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